These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 7542840)

  • 1. Risperidone for treating dementia-associated aggression.
    Jeanblanc W; Davis YB
    Am J Psychiatry; 1995 Aug; 152(8):1239. PubMed ID: 7542840
    [No Abstract]   [Full Text] [Related]  

  • 2. Behavioral and psychological symptoms in patients with dementia as a target for pharmacotherapy with risperidone.
    Rabinowitz J; Katz IR; De Deyn PP; Brodaty H; Greenspan A; Davidson M
    J Clin Psychiatry; 2004 Oct; 65(10):1329-34. PubMed ID: 15491235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risperidone for psychotic and behavioural symptoms in Lewy body dementia.
    Allen RL; Walker Z; D'Ath PJ; Katona CL
    Lancet; 1995 Jul; 346(8968):185. PubMed ID: 7541499
    [No Abstract]   [Full Text] [Related]  

  • 4. Antipsychotic treatment of psychosis and agitation in the elderly.
    Daniel DG
    J Clin Psychiatry; 2000; 61 Suppl 14():49-52. PubMed ID: 11154017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of oxcarbazepine in the treatment of agitation and aggression in severe dementia.
    Sommer OH; Aga O; Cvancarova M; Olsen IC; Selbaek G; Engedal K
    Dement Geriatr Cogn Disord; 2009; 27(2):155-63. PubMed ID: 19182483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological treatment of behavioural and psychological symptoms of dementia in psychogeriatric inpatient units.
    Restifo S; Lemon V; Waters F
    Australas Psychiatry; 2011 Feb; 19(1):59-63. PubMed ID: 21189108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Galantamine versus risperidone for agitation in people with dementia: a randomized, twelve-week, single-center study.
    Freund-Levi Y; Bloniecki V; Auestad B; Tysen Bäckström AC; Lärksäter M; Aarsland D
    Dement Geriatr Cogn Disord; 2014; 38(3-4):234-44. PubMed ID: 24969380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and tolerability of carbamazepine for agitation and aggression in dementia.
    Tariot PN; Erb R; Podgorski CA; Cox C; Patel S; Jakimovich L; Irvine C
    Am J Psychiatry; 1998 Jan; 155(1):54-61. PubMed ID: 9433339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroleptic sensitivity to risperidone in Lewy body dementia.
    McKeith IG; Ballard CG; Harrison RW
    Lancet; 1995 Sep; 346(8976):699. PubMed ID: 7544860
    [No Abstract]   [Full Text] [Related]  

  • 10. Use of low-dose gabapentin for aggressive behavior in vascular and Mixed Vascular/Alzheimer Dementia.
    Cooney C; Murphy S; Tessema H; Freyne A
    J Neuropsychiatry Clin Neurosci; 2013; 25(2):120-5. PubMed ID: 23686029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risperidone for psychosis of Alzheimer's disease and mixed dementia: results of a double-blind, placebo-controlled trial.
    Brodaty H; Ames D; Snowdon J; Woodward M; Kirwan J; Clarnette R; Lee E; Greenspan A
    Int J Geriatr Psychiatry; 2005 Dec; 20(12):1153-7. PubMed ID: 16315159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Memantine in the treatment of dementia.
    Maggiore C; Locatelli L; Grandi FC; Pizzolato G;
    Neuroepidemiology; 2007; 28(2):118-9. PubMed ID: 17409774
    [No Abstract]   [Full Text] [Related]  

  • 13. Agitated behavior relieved following treatment of cervical dystonia in dementia.
    Auchus AP; Freeman A; Green RC
    Neurology; 1995 Feb; 45(2):393. PubMed ID: 7531826
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical experience with risperidone.
    Fras I; Major LF
    J Am Acad Child Adolesc Psychiatry; 1995 Jul; 34(7):833. PubMed ID: 7544342
    [No Abstract]   [Full Text] [Related]  

  • 15. Risperidone and dementia-related aggression: new indication. A last resort, no better than haloperidol.
    Prescrire Int; 2009 Dec; 18(104):248. PubMed ID: 20025088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factor analysis of the Cohen-Mansfield Agitation Inventory in three large samples of nursing home patients with dementia and behavioral disturbance.
    Rabinowitz J; Davidson M; De Deyn PP; Katz I; Brodaty H; Cohen-Mansfield J
    Am J Geriatr Psychiatry; 2005 Nov; 13(11):991-8. PubMed ID: 16286443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacotherapy of behavioral and psychological symptoms of dementia: time for a different paradigm?
    Rojas-Fernandez CH; Lanctot KL; Allen DD; MacKnight C
    Pharmacotherapy; 2001 Jan; 21(1):74-102. PubMed ID: 11191740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of agitation, aggression, and psychosis associated with dementia: a pooled analysis including three randomized, placebo-controlled double-blind trials in nursing home residents treated with risperidone.
    De Deyn PP; Katz IR; Brodaty H; Lyons B; Greenspan A; Burns A
    Clin Neurol Neurosurg; 2005 Oct; 107(6):497-508. PubMed ID: 15922506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treating dementia patients with vascular lesions with donepezil: a preliminary analysis.
    Thomas DA; Libon DJ; Ledakis GE
    Appl Neuropsychol; 2005; 12(1):12-8. PubMed ID: 15788218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measurement of the effects of antidementia agents.
    Siegfried KR
    Clin Neuropharmacol; 1992; 15 Suppl 1 Pt A():592A-593A. PubMed ID: 1498964
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.